These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 12907612)

  • 1. Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer.
    Wang L; Habuchi T; Tsuchiya N; Mitsumori K; Ohyama C; Sato K; Kinoshita H; Kamoto T; Nakamura A; Ogawa O; Kato T
    Cancer Res; 2003 Aug; 63(15):4407-11. PubMed ID: 12907612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of insulin-like growth factor (IGF) binding protein-3 (IGFBP-3) gene polymorphism with the susceptibility to development of prostate cancer and influence on serum levels of IGF-I, and IGFBP-3.
    Safarinejad MR; Shafiei N; Safarinejad S
    Growth Horm IGF Res; 2011 Jun; 21(3):146-54. PubMed ID: 21536469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10.
    Li Z; Habuchi T; Tsuchiya N; Mitsumori K; Wang L; Ohyama C; Sato K; Kamoto T; Ogawa O; Kato T
    Carcinogenesis; 2004 Feb; 25(2):237-40. PubMed ID: 14604900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A gain of function TGFB1 polymorphism may be associated with late stage prostate cancer.
    Ewart-Toland A; Chan JM; Yuan J; Balmain A; Ma J
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):759-64. PubMed ID: 15159307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of IGFBP3 gene polymorphisms on IGFBP3 serum levels and the risk of prostate cancer in low-risk Korean men.
    Park K; Kim JH; Jeon HG; Byun SS; Lee E
    Urology; 2010 Jun; 75(6):1516.e1-7. PubMed ID: 20350746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population.
    Li Z; Habuchi T; Mitsumori K; Kamoto T; Kinoshitu H; Segawa T; Ogawa O; Kato T
    J Urol; 2003 Jun; 169(6):2378-81. PubMed ID: 12771801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
    Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of codon 10 polymorphism of the transforming growth factor beta 1 gene with prostate cancer and hyperplasia in an Iranian population.
    Omrani MD; Taghipour-Bazargani S; Salari-Lak S; Bagheri M
    Urol Int; 2009; 83(3):329-32. PubMed ID: 19829035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population.
    Habuchi T; Suzuki T; Sasaki R; Wang L; Sato K; Satoh S; Akao T; Tsuchiya N; Shimoda N; Wada Y; Koizumi A; Chihara J; Ogawa O; Kato T
    Cancer Res; 2000 Jan; 60(2):305-8. PubMed ID: 10667581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk.
    Singal R; Ferdinand L; Das PM; Reis IM; Schlesselman JJ
    Int J Oncol; 2004 Nov; 25(5):1465-71. PubMed ID: 15492840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.
    Chokkalingam AP; McGlynn KA; Gao YT; Pollak M; Deng J; Sesterhenn IA; Mostofi FK; Fraumeni JF; Hsing AW
    Cancer Res; 2001 Jun; 61(11):4333-6. PubMed ID: 11389055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between bladder cancer and a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) gene.
    Safarinejad MR; Shafiei N; Safarinejad SH
    Arch Toxicol; 2011 Oct; 85(10):1209-18. PubMed ID: 21347663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.
    Chen C; Freeman R; Voigt LF; Fitzpatrick A; Plymate SR; Weiss NS
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2461-6. PubMed ID: 17164371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of an E-cadherin gene promoter polymorphism for risk and disease severity of prostate cancer in a Japanese population.
    Goto T; Nakano M; Ito S; Ehara H; Yamamoto N; Deguchi T
    Urology; 2007 Jul; 70(1):127-30. PubMed ID: 17656222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.
    Jerónimo C; Varzim G; Henrique R; Oliveira J; Bento MJ; Silva C; Lopes C; Sidransky D
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):445-50. PubMed ID: 12010858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP1A1 and GSTM1 polymorphic genotypes in patients with prostate cancer in a Turkish population.
    Aktas D; Hascicek M; Sozen S; Ozen H; Tuncbilek E
    Cancer Genet Cytogenet; 2004 Oct; 154(1):81-5. PubMed ID: 15381379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human kallikrein-2 gene polymorphism is associated with the occurrence of prostate cancer.
    Chiang CH; Hong CJ; Chang YH; Chang LS; Chen KK
    J Urol; 2005 Feb; 173(2):429-32. PubMed ID: 15643194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TSP1 and MMP9 genetic variants in sporadic prostate cancer.
    Sfar S; Saad H; Mosbah F; Gabbouj S; Chouchane L
    Cancer Genet Cytogenet; 2007 Jan; 172(1):38-44. PubMed ID: 17175378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 Codon 72 and p21 codon 31 polymorphisms in prostate cancer.
    Huang SP; Wu WJ; Chang WS; Wu MT; Chen YY; Chen YJ; Yu CC; Wu TT; Lee YH; Huang JK; Huang CH
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2217-24. PubMed ID: 15598783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome.
    Sfar S; Hassen E; Saad H; Mosbah F; Chouchane L
    Cytokine; 2006 Jul; 35(1-2):21-8. PubMed ID: 16908180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.